In this engaging webinar, we will delve into the critical realm of surfactants, shedding light on their significance in formulation development for biologics and gene and cell therapy products. The main focus will be on the root-cause analysis of polysorbate degradation, unraveling the mysteries surrounding this common challenge in pharmaceutical formulations. We will furthermore explore the nuances of polysorbate and poloxamer characterization, focusing on presenting a novel approach to their isolation from typical drug product matrices.
Dr. Zegota will guide participants through the application of multidimensional liquid chromatography, emphasizing a robust methodology for online sample preparation and surfactant analysis. The aim is to provide attendees with an effective strategy and practical approach to improve the accuracy and efficiency of their analytical processes.
Prof. Schöneich will provide new insights into the role of free fatty acids for polysorbate stability, presenting cutting-edge research that goes beyond conventional understanding.
Participants can expect to broaden their knowledge base and gain a deeper understanding of polysorbate degradation. Whether you are an experienced researcher, a formulation scientist or a professional in the pharmaceutical field, this webinar is a unique opportunity to stay abreast of the latest advancements in surfactant analysis. Join us for an informative session that will not only highlight the challenges, but also provide practical solutions to improve your analytical practices and contribute to formulation success. Don’t miss this valuable opportunity to engage with experts and enhance your expertise in surfactant science.
<span>By ticking this box, you agree to the privacy policies of <a href=”https://www.coriolis-pharma.com/data-privacy/” style=”color:white; text-decoration: underline;” target=”_blank”>Coriolis Pharma</a> and <a href=”/wp-content/uploads/2023/08/Livestorm-privacy-policy-en.pdf” style=”color:white; text-decoration: underline;” target=”_blank”>Livestorm</a>, consenting to receiving communications related to this topic and other products or services within their portfolio</span>